Pegavision Corp
TWSE:6491
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
Aurobindo Pharma Ltd
NSE:AUROPHARMA
|
IN |
Pegavision Corp
Operating Expenses
Pegavision Corp
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Pegavision Corp
TWSE:6491
|
Operating Expenses
-NT$1.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medtecs International Corporation Ltd
SGX:546
|
Operating Expenses
-$17.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Visco Vision Inc
TWSE:6782
|
Operating Expenses
-NT$756m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
SciVision Biotech Inc
TWSE:1786
|
Operating Expenses
-NT$448.5m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-15%
|
|
|
OK Biotech Co Ltd
TWSE:4155
|
Operating Expenses
-NT$357m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Pegavision Corp
Glance View
Pegavision Corp. focusing on research, development, manufacture and marketing of soft contact lenses and the medical optic devices. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2014-12-30. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Pegavision Corp's Operating Expenses?
Operating Expenses
-1.9B
TWD
Based on the financial report for Dec 31, 2025, Pegavision Corp's Operating Expenses amounts to -1.9B TWD.
What is Pegavision Corp's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-10%
Over the last year, the Operating Expenses growth was -8%. The average annual Operating Expenses growth rates for Pegavision Corp have been -8% over the past three years , -10% over the past five years .
